TOTAL global spending on medicines is forecast to reach $1.5 trillion by 2021, up 33% from 2016 levels, even as annual growth moderates from the record pace set in 2014 and 2015, according to new research released from the QuintilesIMS Institute.
While historically large numbers of new medicines will emerge from the R&D pipeline in the next five years, pricing and market access pressures, lower volume growth in "pharmerging" markets and greater savings from patent expiries will restrain growth - CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Dec 16
